Diabetic Retinopathy Market Analysis, Segments, Size, Share, Industry Growth and Recent Trends by Forecast to – EIN News

Read Time:7 Minute, 18 Second

There were 764 press releases posted in the last 24 hours and 183,614 in the last 365 days.
Reports And Data
Rising prevalence of diabetes and increasing incidences of blindness among people with severe diabetic conditions are expected to fuel the global market growth
NEW YORK, NY, UNITED STATES, December 7, 2021 /EINPresswire.com/ — The global diabetic retinopathy market size is expected to reach USD by 14.95 Billion 2028 at a CAGR of 7.10%, according to a new report by Reports and Data. Rising prevalence of chronic conditions such as diabetes, increasing cases of diabetic retinopathy among diabetic patients, and growing preferences for technologically advanced and minimally invasive procedures are among the major factors responsible for the growth of the global diabetic retinopathy market in the upcoming years. Booming geriatric population worldwide and their growing susceptibility to chronic diseases such as diabetes, cardiovascular disorders, and sleep disorders further boost market growth to a significant extent.
Diabetic retinopathy is a severe medical condition in which diabetes affects the eyes. The principal cause of diabetic retinopathy is damage to the blood vessels of the light-sensitive tissue of the retina. The most common symptoms of this condition include blurred vision, fluctuating vision, dark or empty areas in the vision, impaired color vision, and vision loss. Excessive amount of sugar in blood leads to the blockage of the tiny blood vessels of the retina and hamper blood supply. Mild-to-moderate cases of diabetic retinopathy may be treated with the help of effective diabetes management; however, advanced cases require laser treatment or surgical procedures.
Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/1484
A comprehensive analysis of the value chain and downstream raw materials and upstream essentials is offered in the report. The market report also covers technical data, manufacturing and production costs, research and development activities, regulatory framework, macro and micro-economic factors, and globalization. The report further segments the Diabetic Retinopathy market on the basis of key companies, product types, applications, and key regions to impart better understanding of the Diabetic Retinopathy market.
Leading Companies Profiled in the Report are:
Novartis AG, Bayer Healthcare, Regeneron Pharmaceuticals Inc., ThromboGenics, Actavis Plc, Sirnaomics, Genentech, Alimera Sciences, Glycadia Pharmaceuticals, Ampio Pharmaceuticals, Kowa Group, and BCN Peptides are some of the renowned companies operating in the global diabetic retinopathy market.
Some Key Highlights in the Report:
• Non-proliferative diabetic retinopathy segment is projected to register the highest CAGR of 7.5% over the forecast period. Rising prevalence of non-proliferative diabetic retinopathy among diabetic patients is one of the most vital factors driving this segment’s growth.
• On the basis of management, the anti-VEGF segment dominated tin terms of revenue in 2020. The segment is expected to maintain its dominance throughout the forecast period, owing to increasing applications of anti-VEGF drugs including Eylea, Lucentis, Avastin, and Macugen in the treatment of mild-to-moderate cases of diabetic retinopathy is one of the key factors accountable for the growth of this segment.
• Among the various distribution channels, the hospitals segment held the largest revenue share in the global diabetic retinopathy market in 2020. Increasing availability of diagnostic instruments in hospitals and pharmacies worldwide and growing number of treatment procedures for diabetic retinopathy bolster the growth of this segment.
• The North America diabetic retinopathy market is the most dominant regional market in terms of revenue. Growing prevalence of diabetes, increasing use of anti-VEGF drugs including Avastin, Eylea, and Lucentis for diabetic retinopathy, rising patient awareness, and the presence of state-of-the-art healthcare infrastructure in North America are the primary factors accountable for the regional market growth. The Asia Pacific market is the fastest-growing regional market and is expected to display a robust CAGR of 8.3% over the forecast period.
For the purpose of this report, the global diabetic retinopathy market is segmented on the basis of type, disease form, management, distribution channel, and region:
Type (Revenue, USD Billion; 2020-2028)
• Mild
• Moderate
• Severe
Disease Form (Revenue, USD Billion; 2020-2028)
• Proliferative diabetic retinopathy
• Non-proliferative diabetic retinopathy
Management (Revenue, USD Billion; 2020-2028)
• Anti-VEGF
• Intraocular steroid injection
• Laser surgery
• Vitrectomy
Distribution channel (Revenue, USD Billion; 2020-2028)
• Eye clinics
• Hospitals
• Retail pharmacies
• Online pharmacies
• Ambulatory surgical centers
• Other
Key Regions Covered in the Report:
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1484
Market Overview:
The pharma and healthcare industry, over the recent past, has undergone a paradigm shift with regards to the adoption of advanced technologies. Integration of AI, ML, 3D printing, and AR/VR have accelerated the R&D process, develop innovative and personalized medicines and therapies, and have improved efficiency and effectiveness of overall healthcare processing thereby improving patient outcomes. In addition, growing popularity and acceptance of wearable tech that enables patients to manage their health and make fruitful decisions and increasing integration of patient monitoring systems have further contributed to the revenue growth of the market. Progress in genomics and proteomics, focus on personalized medicine, and increasing number of clinical trials for pipeline therapeutics are further expected to create lucrative opportunities for key players in the market.
Key Benefits of the Global Diabetic Retinopathy Market Report:
• In-depth analysis of the market potential, threats, limitations, growth prospects and opportunities, drivers, restraints, challenges, and risks
• Analysis of the market opportunities and key trends to help stakeholders capitalize on the emerging prospects
• Analysis and accurate forecast estimation of the Global Diabetic Retinopathy Market
• Study of the key players including SWOT analysis and Porter’s Five Forces
• Analysis of each segment and sub-segment of the market to determine the growth trends and their market contribution
• Study of the developments in the competitive landscape such as agreements, partnerships, expansions, new product launches and brand promotions, and other market features
To know more about the report @ https://www.reportsanddata.com/report-detail/diabetic-retinopathy-market
Highlights of the TOC of the report:
• Chapter 1: Market overview
• Chapter 2: Global Diabetic Retinopathy market analysis
• Chapter 3: Regional analysis of the Diabetic Retinopathy industry
• Chapter 4: Market segmentation based on types and applications
• Chapter 5: Revenue analysis based on types and applications
• Chapter 6: Market share
• Chapter 7: Competitive Landscape
• Chapter 8: Drivers, Restraints, Challenges, and Opportunities
• Chapter 9: Gross Margin and Price Analysis
• So on
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1484
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse More Reports:
Digital Radiography Market @ https://www.medgadget.com/2021/10/digital-radiography-market-growth-driven-by-rapid-digitization-in-the-healthcare-sector-reports-and-data.html
Infusion Pump Market @ https://www.medgadget.com/2021/10/infusion-pump-market-growth-driven-by-rising-demand-for-specialty-infusion-pumps-to-treat-chronic-disease-reports-and-data.html
Anxiety Disorder and Depression Treatment Market @ https://www.medgadget.com/2021/10/anxiety-disorder-and-depression-treatment-market-growth-driven-by-increasing-need-to-treat-mental-health-issues-worldwide-reports-and-data.html
Phototherapy Market @ https://www.medgadget.com/2021/10/phototherapy-market-growth-driven-by-increasing-need-to-treat-skin-diseases-worldwide-reports-and-data.html
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Tushar Rajput
Reports and Data
+18008193052 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
You just read:

EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™, tries to define some of the boundaries that are reasonable in today’s world. Please see our Editorial Guidelines for more information.

Follow EIN Presswire
© 1995-2021 IPD Group, Inc. dba EIN Presswire All Right Reserved.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

4 thoughts on “Diabetic Retinopathy Market Analysis, Segments, Size, Share, Industry Growth and Recent Trends by Forecast to – EIN News

  1. Good post and right to the point. I am not sure if this is actually the best place to ask but do you people have any thoughts on where to get some professional writers? Thx 🙂

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Pediatric brain tumors like the one that killed Nick Cannon’s son are rare but serious in infants – NBC News
Next post Pharmaceutical API Manufacturing Global Market Research Report 2021: Focus on Chemical API, Biological API, Innovative Drugs, Generics, OTC – ResearchAndMarkets.com – Yahoo Finance
Close